Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Petros Pharmaceuticals, Inc. (PTPI) had Return on Tangible Equity of -136.34% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-14.40M |
|
-- |
|
-- |
|
$0.99M |
|
$-0.99M |
|
$0.03M |
|
$-0.96M |
|
$-0.96M |
|
$-0.96M |
|
$-0.96M |
|
$-0.96M |
|
$-0.96M |
|
$-0.99M |
|
$-0.99M |
|
47.39M |
|
47.39M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$3.55M |
|
-- |
|
-- |
|
$3.55M |
|
$2.84M |
|
-- |
|
-- |
|
$2.84M |
|
$0.70M |
|
$0.70M |
|
$0.70M |
|
42.37M |
|
| Cash Flow Statement Financials | |
$-1.65M |
|
-- |
|
-- |
|
$5.14M |
|
$3.49M |
|
$-1.65M |
|
$0.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-136.34% |
|
|
Return on Tangible Equity |
-136.34% |
-26.95% |
|
-136.34% |
|
$0.02 |
|
$-0.03 |
|
$-0.03 |
|